Cooper Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.20 M
- Company Age 11 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 0.73%
- Ebitda 1.12%
- Net Worth 51.75%
- Total Assets 4.53%
About Cooper Life Sciences
Cooper Life Sciences Private Limited (CLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 May 2013 and has a history of 11 years and nine months. Its registered office is in Dehradun, Uttarakhand, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Rakesh Bhargava and Abhishek Bhargava serve as directors at the Company.
Company Details
- Location
Dehradun, Uttarakhand, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24100UR2013PTC000676
- Company No.
000676
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 May 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Who are the key members and board of directors at Cooper Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Bhargava  | Director | 10-May-2013 | Current |
| Abhishek Bhargava | Director | 10-May-2013 | Current |
Financial Performance of Cooper Life Sciences.
Cooper Life Sciences Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 0.73% increase in profit. The company's net worth Soared by an impressive increase of 51.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cooper Life Sciences?
In 2017, Cooper Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Cooper Pharma LimitedRakesh Bhargava and Abhishek Bhargava are mutual person
Dynamic Laboratories Pvt LtdRakesh Bhargava is a mutual person
Cooper Biotech Private LimitedRakesh Bhargava and Abhishek Bhargava are mutual person
- Dw Customer Support Private Limited
Rakesh Bhargava is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cooper Life Sciences?
Unlock and access historical data on people associated with Cooper Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cooper Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cooper Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.